Amneal (NYSE: AMRX) is a generics manufacturer headquartered in Bridgewater, New Jersey.

The company was formed in May 2018 following a merger of Impax Laboratories and a company also called Amneal.

As of May 2018, it is the fifth-largest generics manufacturer in the USA.